Stock ASIA ASIA GREEN BIOTECHNOLOGY CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Asia Green Biotechnology Corp.

Equities

ASIA

CA04522C1041

Pharmaceuticals

Market Closed - Canadian Securities Exchange
Other stock markets
 18:34:38 06/02/2024 GMT 		5-day change 1st Jan Change
0.015 CAD +50.00% Intraday chart for Asia Green Biotechnology Corp. -100.00% -100.00%
04-12 Asia Green Biotechnology Corp. Announces Discontinuation of Any Further Activities in Asia, in Particular, in Cambodia and Thailand CI
02-21 Burton Growers Ltd. & Green Sight Agri-Holdings Inc. entered into a non-binding letter of intent to acquire Asia Green Biotechnology Corp. for CAD 4 million in a reverse merger transaction. CI

Valuation

Fiscal Period: December 2019 2020 2021 2022
Capitalization 1 1.631 3.443 1.45 0.5437
Enterprise Value (EV) 1 0.6092 3.062 1.533 0.7563
P/E ratio -1.38 x -4.83 x -2.49 x -2.73 x
Yield - - - -
Capitalization / Revenue - - - -
EV / Revenue - - - -
EV / EBITDA - - - -
EV / FCF -1,816,988 x -7,301,554 x -6,153,219 x -16,897,583 x
FCF Yield -0% -0% -0% -0%
Price to Book 1.69 x 8.34 x -18.9 x -1.98 x
Nbr of stocks (in thousands) 36,247 36,247 36,247 36,247
Reference price 2 0.0450 0.0950 0.0400 0.0150
Announcement Date 09/03/20 15/03/21 02/05/22 06/04/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022
Net sales - - - - -
EBITDA - - - - -
EBIT 1 -0.7838 -0.6748 -0.5303 -0.4943 -0.162
Operating Margin - - - - -
Earnings before Tax (EBT) 1 -0.9216 -0.7672 -0.5528 -0.5245 -0.1983
Net income 1 -0.9216 -0.7672 -0.5528 -0.5245 -0.1983
Net margin - - - - -
EPS 2 -0.0580 -0.0326 -0.0197 -0.0161 -0.005492
Free Cash Flow - -0.3353 -0.4194 -0.2491 -0.0448
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 29/04/19 09/03/20 15/03/21 02/05/22 06/04/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022
Net Debt 1 - - - 0.08 0.21
Net Cash position 1 0.48 1.02 0.38 - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - -0.34 -0.42 -0.25 -0.04
ROE (net income / shareholders' equity) - -110% -80.2% -312% 113%
ROA (Net income/ Total Assets) - -52.4% -44.3% -111% -110%
Assets 1 - 1.463 1.248 0.4735 0.1806
Book Value Per Share 2 0.0100 0.0300 0.0100 -0 -0.0100
Cash Flow per Share 2 0.0200 0.0300 0.0100 0 0
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 29/04/19 09/03/20 15/03/21 02/05/22 06/04/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Alternative Medicine

1st Jan change Capi.
ASIA GREEN BIOTECHNOLOGY CORP. Stock Asia Green Biotechnology Corp.
-100.00% 398K
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+45.15% 6.34B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-14.00% 4.61B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+9.54% 3.39B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-8.99% 3.29B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+50.03% 2.02B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-6.97% 1.73B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-0.31% 1.67B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+50.00% 1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-10.61% 1.59B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. ASIA Stock
  4. Financials Asia Green Biotechnology Corp.